For: | Gilman C, Heller T, Koh C. Chronic hepatitis delta: A state-of-the-art review and new therapies. World J Gastroenterol 2019; 25(32): 4580-4597 [PMID: 31528088 DOI: 10.3748/wjg.v25.i32.4580] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i32/4580.htm |
Number | Citing Articles |
1 |
V. G. Akimkin, Z. B. Ponezheva, Kh. G. Omarova, Yu. А. Goloverova, S. V. Ugleva, S. V. Shabalina. The prevalence of viral hepatitis D in the world. Epidemiology and Vaccinal Prevention 2022; 21(3): 90 doi: 10.31631/2073-3046-2022-21-3-90-95
|
2 |
Maria Paola Anolli, Elisabetta Degasperi, Pietro Lampertico. Current and Evolving Management of Chronic Hepatitis Delta Virus (HDV) Infection. Current Hepatology Reports 2023; 22(3): 138 doi: 10.1007/s11901-023-00606-7
|
3 |
Stephanie Jung, Sebastian Maximilian Altstetter, Ulrike Protzer. Innate immune recognition and modulation in hepatitis D virus infection. World Journal of Gastroenterology 2020; 26(21): 2781-2791 doi: 10.3748/wjg.v26.i21.2781
|
4 |
Maria Buti, Heiner Wedemeyer, Soo Aleman, Vladimir Chulanov, Viacheslav Morozov, Olga Sagalova, Tatiana Stepanova, Robert G. Gish, Andrew Lloyd, Ankita M. Kaushik, Vithika Suri, Dmitry Manuilov, Anu O. Osinusi, John F. Flaherty, Pietro Lampertico. Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide. Journal of Hepatology 2024; doi: 10.1016/j.jhep.2024.06.031
|
5 |
A. S. Zheleznova, K. A. Svirin, M. Yu. Kartashov. Modern aspects of anti-viral therapy for hepatitis D. Journal Infectology 2024; 16(3): 24 doi: 10.22625/2072-6732-2024-16-3-24-35
|
6 |
Emuejevuoke Umukoro, Joseph J. Alukal, Kevin Pak, Julio Gutierrez. State of the Art. Clinics in Liver Disease 2023; 27(4): 937 doi: 10.1016/j.cld.2023.05.008
|
7 |
Melissa Montoya-Guzmán, Carolina Posada-Álvarez, Laura Camila Lopera-Restrepo, Diana di Filippo-Villa, María-Cristina Navas. Infección por el virus de la hepatitis delta. Hepatología 2020; : 116 doi: 10.52784/27112330.120
|
8 |
·塔拉甫 唐努尔. Research Progress on Epidemiological Characteristics and Clinical Manifestations of Hepatitis D. Advances in Clinical Medicine 2023; 13(08): 13603 doi: 10.12677/ACM.2023.1381901
|
9 |
Lu Yang, Di Zhou, Kächele Martin, Jun Wu, Mingfa Chen, Mengji Lu, Dongliang Yang, Ulrike Protzer, Michael Roggendorf, Jingjiao Song. Aborted infection of human sodium taurocholate cotransporting polypeptide (hNTCP) expressing woodchuck hepatocytes with hepatitis B virus (HBV). Virus Genes 2023; 59(6): 823 doi: 10.1007/s11262-023-02031-w
|
10 |
Calvin Pan, Robert Gish, Ira M. Jacobson, Ke-Qin Hu, Heiner Wedemeyer, Paul Martin. Diagnosis and Management of Hepatitis Delta Virus Infection. Digestive Diseases and Sciences 2023; 68(8): 3237 doi: 10.1007/s10620-023-07960-y
|
11 |
Tommaso Stroffolini, Filomena Morisco, Luigina Ferrigno, Giuseppina Pontillo, Giuseppina Iantosca, Valentina Cossiga, Simonetta Crateri, Maria Elena Tosti. Acute Delta Hepatitis in Italy spanning three decades (1991–2019): Evidence for the effectiveness of the hepatitis B vaccination campaign. Journal of Viral Hepatitis 2022; 29(1): 78 doi: 10.1111/jvh.13620
|
12 |
Felice Alfonso Nava, Giulia Bassetti, Marco Cristofoletti, Massimo Fornaini, Raffaele Geraci, Marina Paties, Carlo Poggi, Stefano Tolio, Claudio Pilerci. Hepatitis delta is a public health concern in the community setting: The role of prison health care units in limiting the spread of infection in general population. MISSION 2022; (56): 43 doi: 10.3280/mis56-2020oa12975
|
13 |
Tatyana Kushner. Delta hepatitis epidemiology and the global burden of disease. Journal of Viral Hepatitis 2023; 30(S1): 5 doi: 10.1111/jvh.13797
|
14 |
Kathryn Jack, Rachel Jackson, William Lucien Irving, Soe Thiha Maung. Hepatitis D Virus Status Among People With Hepatitis B Virus Infection: A Disconnect Between Guidelines and Practice. GastroHep 2024; 2024(1) doi: 10.1155/2024/6622276
|
15 |
Eirini D. Tseligka, Sophie Clément, Francesco Negro. HDV Pathogenesis: Unravelling Ariadne’s Thread. Viruses 2021; 13(5): 778 doi: 10.3390/v13050778
|
16 |
Priyanka Kumar, Catherine Freeland, Sierra Bodor, Sean Farrell, Chari Cohen, Rosemary Frasso. Needs of Individuals Living With Hepatitis Delta Virus and Their Caregivers, 2016–2019. Preventing Chronic Disease 2020; 17 doi: 10.5888/pcd17.200324
|
17 |
Chrong-Reen Wang, Hung-Wen Tsai. Human hepatitis viruses-associated cutaneous and systemic vasculitis. World Journal of Gastroenterology 2021; 27(1): 19-36 doi: 10.3748/wjg.v27.i1.19
|
18 |
Pavel O. Bogomolov, Vladimir T. Ivashkin, Alexey O. Bueverov, Igor V. Maev, Olga I. Sagalova, Snezhana S. Sleptsova, Nikolay D. Yushuk, Denis A. Gusev, Konstantin V. Zhdanov, Vladimir P. Chulanov. Efficacy and safety of bulevirtide in patients with chronic hepatitis D and compensated cirrhosis. Terapevticheskii arkhiv 2021; 93(11): 1290 doi: 10.26442/00403660.2021.11.201163
|
19 |
Zoë Post, Nancy Reau. What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?. Clinics in Liver Disease 2023; 27(4): 973 doi: 10.1016/j.cld.2023.05.011
|
20 |
Akerke Auanassova, Marlen Yessirkepov. Clinical and anamnestic features of patients with systemic vasculitis: a single-center retrospective study. Rheumatology International 2024; 44(4): 687 doi: 10.1007/s00296-024-05533-4
|
21 |
MERYEM GUVENIR, AYSE ARIKAN. Hepatitis B Virus: From Diagnosis to Treatment. Polish Journal of Microbiology 2020; 69(4): 391 doi: 10.33073/pjm-2020-044
|
22 |
Ifeorah M. Ijeoma, Yusuf Musa. Treatment and Management of Tropical Liver Disease. 2025; : 24 doi: 10.1016/B978-0-323-87031-3.00013-5
|
23 |
F. Higuera-de-la-Tijera, G.E. Castro-Narro, J.A. Velarde-Ruiz Velasco, E. Cerda-Reyes, R. Moreno-Alcántar, I. Aiza-Haddad, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, M.S. González-Huezo, E. Márquez-Guillén, L.E. Muñóz-Espinosa, J.L. Pérez-Hernández, M.V. Ramos-Gómez, J. Sierra-Madero, J.F. Sánchez-Ávila, A. Torre-Delgadillo, R. Torres, E.R. Marín-López, D. Kershenobich, E. Wolpert-Barraza. Asociación Mexicana de Hepatología A.C. Guía Clínica de Hepatitis B. Revista de Gastroenterología de México 2021; 86(4): 403 doi: 10.1016/j.rgmx.2021.04.002
|
24 |
Alexander Churkin, Stephanie Lewkiewicz, Vladimir Reinharz, Harel Dahari, Danny Barash. Efficient Methods for Parameter Estimation of Ordinary and Partial Differential Equation Models of Viral Hepatitis Kinetics. Mathematics 2020; 8(9): 1483 doi: 10.3390/math8091483
|
25 |
Jiannis Vlachogiannakos, George V. Papatheodoridis. New epidemiology of hepatitis delta. Liver International 2020; 40(S1): 48 doi: 10.1111/liv.14357
|
26 |
Grazia A Niro, Arianna Ferro, Francesca Cicerchia, Isabella Brascugli, Marilena Durazzo. Hepatitis delta virus: From infection to new therapeutic strategies. World Journal of Gastroenterology 2021; 27(24): 3530-3542 doi: 10.3748/wjg.v27.i24.3530
|
27 |
F. Higuera-de-la-Tijera, G.E. Castro-Narro, J.A. Velarde-Ruiz Velasco, E. Cerda-Reyes, R. Moreno-Alcántar, I. Aiza-Haddad, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, M.S. González-Huezo, E. Márquez-Guillén, L.E. Muñóz-Espinosa, J.L. Pérez-Hernández, M.V. Ramos-Gómez, J. Sierra-Madero, J.F. Sánchez-Ávila, A. Torre-Delgadillo, R. Torres, E.R. Marín-López, D. Kershenobich, E. Wolpert-Barraza. Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B. Revista de Gastroenterología de México (English Edition) 2021; 86(4): 403 doi: 10.1016/j.rgmxen.2021.04.002
|
28 |
Huan Chen. Artificial Intelligence Technology Empowers Communication and Dissemination of New Media Arts. Applied Mathematics and Nonlinear Sciences 2024; 9(1) doi: 10.2478/amns-2024-0354
|
29 |
Rami Zakh, Alexander Churkin, Franziska Totzeck, Marina Parr, Tamir Tuller, Ohad Etzion, Harel Dahari, Michael Roggendorf, Dmitrij Frishman, Danny Barash. A Mathematical Analysis of HDV Genotypes: From Molecules to Cells. Mathematics 2021; 9(17): 2063 doi: 10.3390/math9172063
|
30 |
Megan Glynn, Chari Cohen, Robert G Gish, Richard Andrews, Amy Trang, Beatrice Zovich, Warren Hall, Ryan Clary, Joseph Balestreri, Lori Scott, Rachel Scott, Tamika Jackson, Boatemaa Ntiri-Reid, Alia Southworth, Douglas Dieterich, Thomas Sepe. Advancing research, awareness, screening, and linkage to care to eliminate HDV in the U.S.. Hepatology Communications 2023; 7(7) doi: 10.1097/HC9.0000000000000168
|
31 |
Muhammad Baraa Hammami, Ruhail Kohli, Tinsay Woreta, Mark S. Sulkowski, James P. Hamilton, Lindsey Toman, Behnam Saberi, Jacqueline Laurin, Jacqueline Garonzik Wang, Benjamin Philosophe, Andrew M. Cameron, Ahmet Gurakar. Hepatitis B Virus/Hepatitis D Virus–Coinfected Liver Transplant Candidate Receiving Hepatitis B Virus-Deoxyribonucleic Acid–Positive Allograft and Treated With High-Dose Hepatitis B Immune Globulin. ACG Case Reports Journal 2021; 8(5): e00582 doi: 10.14309/crj.0000000000000582
|
32 |
Berat Ebik, M. Sadik Cangul, Kendal Yalçin. What does quantitative HBsAg level mean in chronic hepatitis D infection?. European Journal of Gastroenterology & Hepatology 2023; 35(3): 320 doi: 10.1097/MEG.0000000000002489
|